Hence, the induction of lipolysis could be a therapeutic target in the context of obesity management, but for that we need to understand both how leptin controls the SNS output to WAT (37) and BAT (38) and how the decrease in energy expenditure observed upon leptin resistance develops, consequently driving the progression of obesity into metabolic syndrome. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.